A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults.
Saved in:
| Title: | A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults. |
|---|---|
| Authors: | Mpendo J; Uganda Virus Research Institute-IAVI, Entebbe, Uganda., Mutua G; Kenya AIDS Vaccine Initiative, University of Nairobi, Nairobi, Kenya., Nyombayire J; Projet San Francisco (PSF), Kigali, Rwanda., Ingabire R; Projet San Francisco (PSF), Kigali, Rwanda., Nanvubya A; Uganda Virus Research Institute-IAVI, Entebbe, Uganda., Anzala O; Kenya AIDS Vaccine Initiative, University of Nairobi, Nairobi, Kenya., Karita E; Projet San Francisco (PSF), Kigali, Rwanda., Hayes P; IAVI, Human Immunology Laboratory, Imperial College, London, United Kingdom., Kopycinski J; IAVI, Human Immunology Laboratory, Imperial College, London, United Kingdom., Dally L; EMMES Corporation, Rockville, Maryland, United States of America., Hannaman D; ICHOR Medical Systems, Inc., San Diego, California, United States of America., Egan MA; Profectus BioSciences, Inc., Tarrytown, New York, United States of America., Eldridge JH; Profectus BioSciences, Inc., Tarrytown, New York, United States of America., Syvertsen K; International AIDS Vaccine Initiative (IAVI), New York, New York, United States of America., Lehrman J; International AIDS Vaccine Initiative (IAVI), New York, New York, United States of America., Rasmussen B; International AIDS Vaccine Initiative (IAVI), New York, New York, United States of America., Gilmour J; IAVI, Human Immunology Laboratory, Imperial College, London, United Kingdom., Cox JH; International AIDS Vaccine Initiative (IAVI), New York, New York, United States of America., Fast PE; International AIDS Vaccine Initiative (IAVI), New York, New York, United States of America., Schmidt C; International AIDS Vaccine Initiative (IAVI), New York, New York, United States of America. |
| Source: | PloS one [PLoS One] 2015 Aug 07; Vol. 10 (8), pp. e0134287. Date of Electronic Publication: 2015 Aug 07 (Print Publication: 2015). |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 26252526 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Mpendo+J%22">Mpendo J</searchLink>; Uganda Virus Research Institute-IAVI, Entebbe, Uganda.<br /><searchLink fieldCode="AU" term="%22Mutua+G%22">Mutua G</searchLink>; Kenya AIDS Vaccine Initiative, University of Nairobi, Nairobi, Kenya.<br /><searchLink fieldCode="AU" term="%22Nyombayire+J%22">Nyombayire J</searchLink>; Projet San Francisco (PSF), Kigali, Rwanda.<br /><searchLink fieldCode="AU" term="%22Ingabire+R%22">Ingabire R</searchLink>; Projet San Francisco (PSF), Kigali, Rwanda.<br /><searchLink fieldCode="AU" term="%22Nanvubya+A%22">Nanvubya A</searchLink>; Uganda Virus Research Institute-IAVI, Entebbe, Uganda.<br /><searchLink fieldCode="AU" term="%22Anzala+O%22">Anzala O</searchLink>; Kenya AIDS Vaccine Initiative, University of Nairobi, Nairobi, Kenya.<br /><searchLink fieldCode="AU" term="%22Karita+E%22">Karita E</searchLink>; Projet San Francisco (PSF), Kigali, Rwanda.<br /><searchLink fieldCode="AU" term="%22Hayes+P%22">Hayes P</searchLink>; IAVI, Human Immunology Laboratory, Imperial College, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Kopycinski+J%22">Kopycinski J</searchLink>; IAVI, Human Immunology Laboratory, Imperial College, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Dally+L%22">Dally L</searchLink>; EMMES Corporation, Rockville, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Hannaman+D%22">Hannaman D</searchLink>; ICHOR Medical Systems, Inc., San Diego, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Egan+MA%22">Egan MA</searchLink>; Profectus BioSciences, Inc., Tarrytown, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Eldridge+JH%22">Eldridge JH</searchLink>; Profectus BioSciences, Inc., Tarrytown, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Syvertsen+K%22">Syvertsen K</searchLink>; International AIDS Vaccine Initiative (IAVI), New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Lehrman+J%22">Lehrman J</searchLink>; International AIDS Vaccine Initiative (IAVI), New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Rasmussen+B%22">Rasmussen B</searchLink>; International AIDS Vaccine Initiative (IAVI), New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Gilmour+J%22">Gilmour J</searchLink>; IAVI, Human Immunology Laboratory, Imperial College, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Cox+JH%22">Cox JH</searchLink>; International AIDS Vaccine Initiative (IAVI), New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Fast+PE%22">Fast PE</searchLink>; International AIDS Vaccine Initiative (IAVI), New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Schmidt+C%22">Schmidt C</searchLink>; International AIDS Vaccine Initiative (IAVI), New York, New York, United States of America. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101285081%22">PloS one</searchLink> [PLoS One] 2015 Aug 07; Vol. 10 (8), pp. e0134287. <i>Date of Electronic Publication: </i>2015 Aug 07 (<i>Print Publication: </i>2015). – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101285081 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1932-6203 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219326203%22">19326203 </searchLink><i>NLM ISO Abbreviation: </i>PLoS One <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26252526 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.pone.0134287 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e0134287 Titles: – TitleFull: A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mpendo J – PersonEntity: Name: NameFull: Mutua G – PersonEntity: Name: NameFull: Nyombayire J – PersonEntity: Name: NameFull: Ingabire R – PersonEntity: Name: NameFull: Nanvubya A – PersonEntity: Name: NameFull: Anzala O – PersonEntity: Name: NameFull: Karita E – PersonEntity: Name: NameFull: Hayes P – PersonEntity: Name: NameFull: Kopycinski J – PersonEntity: Name: NameFull: Dally L – PersonEntity: Name: NameFull: Hannaman D – PersonEntity: Name: NameFull: Egan MA – PersonEntity: Name: NameFull: Eldridge JH – PersonEntity: Name: NameFull: Syvertsen K – PersonEntity: Name: NameFull: Lehrman J – PersonEntity: Name: NameFull: Rasmussen B – PersonEntity: Name: NameFull: Gilmour J – PersonEntity: Name: NameFull: Cox JH – PersonEntity: Name: NameFull: Fast PE – PersonEntity: Name: NameFull: Schmidt C IsPartOfRelationships: – BibEntity: Dates: – D: 07 M: 08 Text: 2015 Aug 07 Type: published Y: 2015 Identifiers: – Type: issn-electronic Value: 1932-6203 Numbering: – Type: volume Value: 10 – Type: issue Value: 8 Titles: – TitleFull: PloS one Type: main |
| ResultId | 1 |
